SNSE - Sensei Biotherapeutics Inc
This page shows which of the focused investors we track hold SNSE and how their positions changed, so you can see how much conviction the group has in the stock.
In Q3 2023 it was held by 1 manager with an aggregate reported value of $80K, which is 0.00% of the combined portfolio.
As of Q3 2023, 1 tracked institutional manager held SNSE (Sensei Biotherapeutics Inc) with an aggregate reported value of $80K — 0.00% of the combined AlphaBaseline portfolio.
Get email alerts when a tracked manager trades SNSE — sign in or create a free account.
- Source
- Curated SEC 13F filings
- Period
- Q3 2023
- Ticker
- SNSE
13F data is delayed and excludes shorts/non-13F assets.
Holders
| 1 | Stanley Druckenmiller - Duquesne Family Office LLC | 0.00% | - | 100,000 | $80K |
Loading holder history for SNSE…